Literature DB >> 1503430

The effects of steroid hormones on a human colon cancer cell line in vitro.

P Lointier1, D M Wildrick, B M Boman.   

Abstract

Estrogen analogues, moxestrol (10(-8)-10(-5) M) and ethinyl estradiol (10(-8)-10(-6) M), produced a 30% and 15% inhibition of LoVo cell growth, respectively, in serum-free Ham's F-10 medium. Under the same conditions, no growth effects were observed on these cells following the addition of progesterone or testosterone (10(-8)-10(-6) M); however, metribolone (10(-8)-10(-6) M), a synthetic androgen with glucocorticoid receptor-binding properties, moderately stimulated cell growth (18%). The synthetic antiandrogen, RU 23908 (10(-6) M), did not reduce metribolone effects, and hydrocortisone (10(-9)-10(-7) M) stimulated LoVo cell growth by 31% in serum-free medium. In medium containing 10% charcoal-treated fetal bovine serum, the inhibitory effects of estrogens were not observed, and the lower concentrations (10(-11) M) of moxestrol and ethinyl estradiol facilitated cell growth (10 to 15%). The other steroid hormones produced the same results as observed with serum-free medium. These data suggest that estrogen and glucocorticoid hormones may play an important role in the growth of colon carcinoma cells. Androgen and progesterone hormones appear to be less significant in this regard. Serum factors alter the effects of estrogen, but not of glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1503430

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  25 in total

1.  Colorectal cancer: surgical prophylaxis and chemoprevention.

Authors:  P G Wardle
Journal:  Ann R Coll Surg Engl       Date:  1996-03       Impact factor: 1.891

2.  Oral contraceptive use and colorectal cancer in the Nurses' Health Study I and II.

Authors:  Brittany M Charlton; Kana Wu; Xuehong Zhang; Edward L Giovannucci; Charles S Fuchs; Stacey A Missmer; Bernard Rosner; Susan E Hankinson; Walter C Willett; Karin B Michels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-10       Impact factor: 4.254

3.  The influence of hormone therapies on colon and rectal cancer.

Authors:  Lina Steinrud Mørch; Øjvind Lidegaard; Niels Keiding; Ellen Løkkegaard; Susanne Krüger Kjær
Journal:  Eur J Epidemiol       Date:  2016-01-12       Impact factor: 8.082

4.  Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study.

Authors:  Millie D Long; Christopher F Martin; Joseph A Galanko; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

5.  Polyp surveillance after surgery for colorectal cancer.

Authors:  Kazushige Kawai; Eiji Sunami; Nelson H Tsuno; Joji Kitayama; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2012-02-03       Impact factor: 2.571

6.  Biphasic actions of estrogen on colon cancer cell growth: possible mediation by high- and low-affinity estrogen binding sites.

Authors:  X Xu; M L Thomas
Journal:  Endocrine       Date:  1995-09       Impact factor: 3.633

Review 7.  Oral contraceptives and cancer: an update.

Authors:  C La Vecchia; A Altieri; S Franceschi; A Tavani
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

8.  A prospective study of oral contraceptive use and colorectal adenomas.

Authors:  Brittany M Charlton; Edward Giovannucci; Charles S Fuchs; Andrew T Chan; Jung Eun Lee; Yin Cao; Stacey A Missmer; Bernard A Rosner; Susan E Hankinson; Walter Willett; Kana Wu; Karin B Michels
Journal:  Cancer Causes Control       Date:  2016-04-28       Impact factor: 2.506

9.  Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.

Authors:  Marc J Gunter; Donald R Hoover; Herbert Yu; Sylvia Wassertheil-Smoller; Thomas E Rohan; JoAnn E Manson; Barbara V Howard; Judith Wylie-Rosett; Garnet L Anderson; Gloria Y F Ho; Robert C Kaplan; Jixin Li; Xiaonan Xue; Tiffany G Harris; Robert D Burk; Howard D Strickler
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

10.  Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer.

Authors:  Tess V Clendenen; Karen L Koenig; Roy E Shore; Mortimer Levitz; Alan A Arslan; Anne Zeleniuch-Jacquotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.